CD3-directed Antibody Interactions

CD3 Receptor Agonists

Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager

Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions

Melanoma

Uveal Neoplasms

<section class="Section" data-sectioncode="34089-3"><a name="s_1100"></a><a name="section-8"></a><p></p><h1>11 DESCRIPTION</h1><p class="First">Tebentafusp-tebn is a bispecific gp100 peptide-HLA-directed T cell receptor CD3 T cell engager. Tebentafusp-tebn has an approximate molecular weight of 77 kDa. Tebentafusp-tebn is produced by recombinant DNA technology in   <span class="Italics">Escherichia coli</span>cells. </p><p>KIMMTRAK (tebentafusp-tebn) injection is supplied in a single-dose vial as a sterile, preservative-free, clear, colorless or slightly yellowish solution for intravenous administration by infusion.</p><p>Each single-dose vial contains tebentafusp-tebn (100 mcg), citric acid monohydrate (0.95 mg), di-sodium hydrogen phosphate (2.91 mg), mannitol (5 mg), polysorbate 20 (0.1 mg) trehalose (25 mg), and water for injection, with a pH of 6.5.</p></section>

KIMMTRAK

tebentafusp

tebentafusp-tebn

0.5 ML tebentafusp-tebn 0.2 MG/ML Injection

Kimmtrak

0.5 ML tebentafusp-tebn 0.2 MG/ML Injection [Kimmtrak]

Psoriasis (PsO)

Psoriatic Arthritis (PsA)

Ankylosing Spondylitis (AS)

Nonradiographic Axial Spondyloarthritis

Taltz

Juvenile Idiopathic Arthritis

Hidradenitis Suppurativa (HS)

Cosentyx

Siliq

Tremfya

Crohn's Disease (CD)

Ulcerative Colitis (UC)

Stelara

Skyrizi

Ilumya

Migraine

Cluster Headache

Migraine Prevention

Emgality

Qulipta

Acute Migraine

Ubrelvy

Nurtec ODT

Vyepti

Aimovig

Ajovy

Breast Cancer: HR+ (HER2-)

Verzenio

Ibrance

Kisqali

Atopic Dermatitis (Eczema)

Cibinqo

Eucrisa

Asthma (injectable)

Asthma OCS Dependent

Nasal Polyposis

Eosinophilic Esophagitis (EoE)

Prurigo Nodularis

Dupixent

Opzelura

Adbry

NSCLC ALK+ OR ROS1+ Disease

Lorbrena

Alecensa

Alunbrig

NSCLC cMET Mutation

Xalkori

Rheumatoid Arthritis (RA)

Xeljanz

Uveitis

Graft Versus Host Disease (GVHD)

Orencia

COVID-19 Treatment

Alopecia Areata

Olumiant

Multiple Sclerosis (MS)

Secondary Progressive Multiple Sclerosis

Zeposia

Rinvoq

Entyvio

Report Adverse Event 

Prescribing Information

Medication Guide 

Submit MSL Request 

Pharmacy List 

How To Order Kimmtrak

Billing & Coding Guide

Coverage Authorization Request 

Coverage Authorization Appeals 

Kimmtrak Connect Enrollment Form 

Kimmtrak Connect Enrollment Form - Online 

Enroll in Patient Savings Program 

Other HCP Resources 

Kimmtrak Connect Brochure

Kimmtrak Connect Support Program 

About Kimmtrak 

Receiving Kimmtrak 

Instructions For Use: HLA-A*02:01–Positive Uveal Melanoma 

Patient Resources